GGMC Announces CEO Succession: Grant Wood to Steer Genomic Medicine into New Era of Growth

The Global Genomic Medicine Collaborative (GGMC) (https://globalgenomics.org) is announcing a significant leadership transition, celebrating the achievements of outgoing CEO, Tejinder 'Teji' K. Rakhra-Burris, and welcoming Grant Wood as the new CEO, effective July 1, 2024.

"I am honored and energized to lead GGMC into its next chapter," said Wood. "I believe that genomics holds the key to transforming healthcare, and GGMC is uniquely positioned to drive that transformation. Building upon the strong foundation laid by Teji, we will focus on expanding collaborations, bolstering networks, and launching targeted projects that will accelerate the integration of genomic medicine globally."

Key Strategies Moving Forward:

Strategic Collaborations: GGMC will forge partnerships with leading industry organizations to identify and execute impactful international projects that advance the use of genomic medicine in patient care.

Expanded Networks: GGMC will broaden its local and country-wide networks to include a diverse range of experts, from training and technology implementation to clinical delivery across multiple specialties.

Targeted Projects: GGMC will launch a portfolio of projects addressing key challenges in genomic medicine, ranging from family health history data collection to the clinical adoption of artificial intelligence.

Celebrating Rakhra-Burris's Legacy

The GGMC community extends its deepest gratitude to outgoing CEO Teji K. Rakhra-Burris for her transformative leadership. During her tenure, GGMC experienced significant growth and made important strides in advancing genomic medicine globally.

"It has been a privilege to serve as CEO of GGMC," said Rakhra-Burris. "I am proud to have worked with such a dedicated team to build a strong foundation that enabled what we have accomplished together. I am confident that GGMC will continue to thrive under Grant's leadership."

About Grant Wood

Grant Wood is an executive technologist with extensive experience in designing and developing innovative healthcare systems, with a focus on precision medicine. He has been an active member of GGMC since 2014, serving on numerous committees and leading key initiatives. Wood is also involved in several other prominent organizations in the technology and genomics space, including Health Level 7 International (HL7), Global Alliance for Genomics and Health (GA4GH), AlphaNet, CDC National Family Health History Group, and other various projects in the field of clinical genomics implementation and innovation.

About GGMC

The Global Genomic Medicine Collaborative is a non-profit organization dedicated to advancing genomic medicine globally. GGMC works with partners around the world to accelerate the translation of genomic research into clinical practice, improve patient care, and reduce health disparities.

Global Genomic Medicine Collaborative
Durham, NC 27705

https://globalgenomics.org

The Global Genomic Medicine Collaborative (GGMC) is a global organization headquartered in North Carolina, USA, with a mission to advance genomic medicine integration efforts worldwide. Built on the need for better coordination and collaboration of genomic medicine organizations and programs across the globe, GGMC strives to bring these efforts together under one roof, leveraging the profound work being done in the genomic medicine arena and improving global health.

This release was published on openPR.